These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10048939)
21. Information from drug companies and opinion leaders. Liberati A; Magrini N BMJ; 2003 May; 326(7400):1156-7. PubMed ID: 12775588 [No Abstract] [Full Text] [Related]
23. [Safety assessment of new products developed by the pharmaceutical industry]. Claude JR Ann Pharm Fr; 2001 Sep; 59(5):324-30. PubMed ID: 11787426 [TBL] [Abstract][Full Text] [Related]
24. The further evolution of biotech. Nagle T; Berg C; Nassr R; Pang K Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762 [TBL] [Abstract][Full Text] [Related]
25. [An interview with Dr. D. Poggiolini, director of the Pharmaceutical Service of the Health Ministry and the Drug Committee of the EEC. Interview by Giuseppe Lojacono]. Poggiolini D Epidemiol Prev; 1988 Dec; 10(37):9. PubMed ID: 2978859 [No Abstract] [Full Text] [Related]
26. The present status of medical physics education and training in Europe: an EFOMP survey. Eudaldo T; Olsen K Phys Med; 2008 Mar; 24(1):3-20. PubMed ID: 18061501 [TBL] [Abstract][Full Text] [Related]
28. Graduate education in the pharmaceutical sciences: how can it better meet the needs of the generic pharmaceutical industry? Till AE Pharm Res; 1997 Jul; 14(7):837-8. PubMed ID: 9244135 [No Abstract] [Full Text] [Related]
29. Internet strategies being implemented by pharmaceutical companies. Goldstein D; Flory J Med Interface; 1997 May; 10(5):48-50. PubMed ID: 10167503 [No Abstract] [Full Text] [Related]
30. Orthodontic specialists education in Europe: past, present and future. van der Linden FP Prog Orthod; 2005; 6(1):14-35. PubMed ID: 15891782 [TBL] [Abstract][Full Text] [Related]
31. A new era in the European marketplace. Wagner M Mod Healthc; 1990 Oct; 20(39):26-7, 30-3. PubMed ID: 10170601 [TBL] [Abstract][Full Text] [Related]
32. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers. Fleuranceau-Morel P Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550 [TBL] [Abstract][Full Text] [Related]
33. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities. Couvreur P; Barguer D; Crommelin DJ; DuchĂȘne D; Engels JW; Kerr DJ; Krogsgaard-Larsen P; Meijer DK; Paoletti R; Wagner E; Eur J Pharm Sci; 2005 Feb; 24(2-3):245-52. PubMed ID: 15776539 [No Abstract] [Full Text] [Related]
34. Twenty-first century graduate education in clinical psychology: a four level matrix model. Snyder CR; Elliott TR J Clin Psychol; 2005 Sep; 61(9):1033-54. PubMed ID: 15965948 [TBL] [Abstract][Full Text] [Related]
35. A word for the new MD/PhD graduate. Silverman M Clin Invest Med; 2002; 25(1-2):6-7. PubMed ID: 12030255 [No Abstract] [Full Text] [Related]
36. The MD/PhD pathway to a career in laboratory medicine. Santoro SA; Mosse CA; Young PP Clin Lab Med; 2007 Jun; 27(2):425-34; abstract ix. PubMed ID: 17556094 [TBL] [Abstract][Full Text] [Related]
37. There is a shortage of students entering our PhD programs in audiology. Burkard RF Am J Audiol; 2004 Dec; 13(2):98. PubMed ID: 15903133 [No Abstract] [Full Text] [Related]
38. [Public health and chemical-pharmaceutical companies]. Ribeiro MA Hist Cienc Saude Manguinhos; 2000 Nov-2001 Feb; 7(3):607-26. PubMed ID: 16683337 [TBL] [Abstract][Full Text] [Related]
40. Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one. Mohl PC Acad Psychiatry; 2005; 29(2):215-21. PubMed ID: 15937270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]